Tag Archives: Vaccine hesitancy

Ross G. Menzies, University of Technology Sydney and Rachel E. Menzies, University of Sydney Vaccines save lives, and have been doing so since the development of the smallpox vaccine more than 200 years ago. However, for vaccines to keep entire communities safe they need to be taken up by very large proportions of the population. Only then can the vaccinated …

Samantha Vanderslott, University of Oxford; Andrew Pollard, University of Oxford, and Seilesh Kadambari, University of Oxford Some of the highest rates of death and serious illness during the pandemic have been among Black, Asian and minority ethnic (BAME) communities. According to government data, Black ethnic groups have the highest diagnosis rates of COVID-19 and people of Bangladeshi ethnicity have twice …

Jonathan Kennedy, Queen Mary University of London At the start of the year, one of the main causes of the EU’s slow rollout of COVID-19 vaccines was lower than expected supplies from AstraZeneca. Fast forward a few weeks and the EU’s vaccination programme still trails far behind the UK and US, but politicians and those in public health now have …

Rodney E. Rohde, Texas State University U.S. Census Bureau, CC BY-ND It may be summer before children under 16 can be vaccinated against COVID-19 in the United States. That’s a problem for reaching herd immunity quickly. Children are a significant portion of the population – roughly 65 million are under the age of 16, making up 20% of people in …

Establishing public trust is now central to any decisions regarding the inoculation of our child population. (Shutterstock) Michael Hefferon, Queen’s University, Ontario As COVID-19 vaccination for adults rolls out, it’s time to consider the wisdom (or otherwise) of vaccinating our children. Indications to vaccinate a child population could include: A pandemic causing severe and widespread illness/mortality in the child population. …

Rob Reddick, The Conversation Coronavirus vaccines are being administered. Pfizer’s COVID-19 vaccine was the first to finish the final stage of testing – known as phase 3 – and the full results have been published. Having assessed the data, countries are beginning to authorise this vaccine for public use and roll it out. Others are not too far behind. The …

Rob Reddick, The Conversation Coronavirus vaccines are being administered. Pfizer’s COVID-19 vaccine was the first to finish the final stage of testing – known as phase 3 – and the full results have been published. Having assessed the data, countries are beginning to authorise this vaccine for public use and roll it out. Others are not too far behind. The …